25 April 2022

Ban on public contracts with Russian companies

The sanctions imposed by the EU against Russia now also prohibit the awarding of public contracts to companies with links to Russia as well as the continued execution of existing contracts with such companies. We provide a summary of the far-reaching consequences resulting from the ban in our GSK Update.

Under the EU Regulation adopted as part of the sanctions against Russia, the following prohibitions apply to public contracting authorities:

• Ban on awarding public contracts to companies with links to Russia
• Ban on the continued execution of contracts already concluded with such companies

Find out in our GSK Update what the practical implications of these prohibitions are for award procedures that are still ongoing as well as for contracts that have already been concluded. We also inform you about any obligations that may result from the ban for contracting authorities and bidders.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 02 February 2023

    GSK Update: The new Transparency International Corruption Perceptions Index 2022

    Read more
  • 23 November 2022

    GSK Update: FAQs on the most important PRIIP requirements as of 01.01.2023

    Read more
  • 06 October 2022

    GSK Update: Real estate transfer tax on share deals – how to approach potential double taxation issues

    Read more
Contact person

Dr. Jenny Mehlitz

Partner*

+49 30 203907-7766

jenny.mehlitz@gsk.de

Dr. Friedrich Ludwig Hausmann

Partner*

+49 30 203907-38

friedrich.hausmann@gsk.de

Leonie Becker, LL.M.

Associate

+49 30 203907-81

leonie.becker@gsk.de

Fabian Schiefner

Associate

+49 30 203907-0

fabian.schiefner@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral